Pyxis Oncology Inc. (PYXS) Business Metric Overview - Stocknear

Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.91
0.30 (18.63%)
At close: Sep 05, 2025, 3:59 PM
1.95
2.09%
After-hours: Sep 05, 2025, 07:54 PM EDT

Pyxis Oncology Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024
Royalty Revenue 8.15M 8.15M 8.15M
Royalty Revenue Growth 0.00% 0.00% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 5.44M 5.87M 5.08M 6.01M 6.08M 8.25M 6.16M 10.67M 6.73M 9.05M 8.12M 9.36M 8.56M 11.32M 9.2M 3.77M 2.74M 2.96M 1.44M 767K 819.5K 819.5K
Selling, General, and Administrative Revenue Growth -7.38% +15.53% -15.50% -1.09% -26.29% +33.88% -42.25% +58.50% -25.66% +11.50% -13.25% +9.39% -24.40% +23.02% +143.90% +37.87% -7.41% +105.21% +87.74% -6.41% 0.00% n/a
Research and Development Revenue 17.13M 17.04M 34.99M 17.74M 13.95M 11.91M 10.84M 14.69M 11.39M 11.9M 29.85M 19.03M 17.17M 20.07M 7.23M 7.85M 3.21M 32.77M 3.14M 2.42M 1.74M 1.74M
Research and Development Revenue Growth +0.52% -51.29% +97.22% +27.15% +17.12% +9.86% -26.17% +28.94% -4.29% -60.14% +56.85% +10.86% -14.45% +177.76% -7.94% +144.90% -90.22% +944.09% +29.44% +39.21% 0.00% n/a